Literature DB >> 27401397

Down-regulation of renin-aldosterone and antidiuretic hormone systems in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Kunihisa Miwa1.   

Abstract

BACKGROUND: Central nervous system dysfunction associated with myalgic encephalomyelitis (ME) has been postulated as the cause of chronic fatigue syndrome (CFS). A small heart or reduced left ventricular volume with reduced cardiac output has been reported to be common in patients with ME. The main circulatory blood volume regulators may be down-regulated.
METHODS: Plasma levels of the neurohumoral factors that regulate circulatory blood volume were determined in 18 patients with ME and 15 healthy subjects (Controls).
RESULTS: The echocardiographic examination revealed that the mean values for the left ventricular end-diastolic diameters, stroke volume index, and cardiac index as well as the mean blood pressure were all significantly smaller in the ME group than in the Controls. The mean plasma renin activity (1.6±1.0ng/ml/h vs. 2.5±1.5ng/ml/h, p=0.06) was considerably lower in the ME group than in the Controls. Both the mean plasma aldosterone (104±37pg/ml vs. 157±67pg/ml, p=0.004) and antidiuretic hormone (ADH) (2.2±1.0pg/ml vs. 3.3±1.5pg/ml, p=0.02) concentrations were significantly lower in the ME group than in the Controls. Desmopressin (120μg), a synthetic version of arginine vasopressin, was orally administered for five successive days to 10 patients with ME. In five patients (50%), the symptoms of orthostatic intolerance during a 10min active standing test were ameliorated in association with a significant increase in urinary osmotic pressure and decrease in heart rate. Furthermore, in five patients (50%), the performance status scores for the activities of daily living were improved.
CONCLUSIONS: Both the renin-aldosterone and ADH systems were down-regulated despite the existence of reduction in cardiac preload and output in patients with ME. Desmopressin improved symptoms in half of the patients.
Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antidiuretic hormone; Chronic fatigue syndrome; Desmopressin; Myalgic encephalomyelitis; Renin–aldosterone system

Mesh:

Substances:

Year:  2016        PMID: 27401397     DOI: 10.1016/j.jjcc.2016.06.003

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  4 in total

Review 1.  Faintly tired: a systematic review of fatigue in patients with orthostatic syncope.

Authors:  Ryan E Y Wu; Farhaan M Khan; Brooke C D Hockin; Trudie C A Lobban; Shubhayan Sanatani; Victoria E Claydon
Journal:  Clin Auton Res       Date:  2022-06-10       Impact factor: 5.625

2.  Ongoing Exercise Intolerance Following COVID-19: A Magnetic Resonance-Augmented Cardiopulmonary Exercise Test Study.

Authors:  James T Brown; Anita Saigal; Nina Karia; Rishi K Patel; Yousuf Razvi; Natalie Constantinou; Jennifer A Steeden; Swapna Mandal; Tushar Kotecha; Marianna Fontana; James Goldring; Vivek Muthurangu; Daniel S Knight
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

3.  Paradigm shift to disequilibrium in the genesis of orthostatic intolerance in patients with myalgic encephalomyelitis and chronic fatigue syndrome.

Authors:  Kunihisa Miwa; Yukichi Inoue
Journal:  Int J Cardiol Hypertens       Date:  2020-05-20

4.  Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis.

Authors:  Maximillian J Nelson; Jasvir S Bahl; Jonathan D Buckley; Rebecca L Thomson; Kade Davison
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.